Cardiometabolic risk refers to the likelihood of developing cardiovascular disease and metabolic disorders due to factors like insulin resistance, hypertension, dyslipidaemia, and central obesity. It is crucial in clinical practice for early identification and prevention of conditions such as type 2 diabetes and atherosclerotic cardiovascular disease, which significantly increase morbidity and mortality.